Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Cash & Equivalents (2018 - 2025)

Zai Lab's Cash & Equivalents history spans 8 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 99.73% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, down 99.73%, while the annual FY2025 figure was $1.2 million, 99.73% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.2 million at Zai Lab, up from $1.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.8 billion in Q2 2021 and bottomed at $1.0 million in Q4 2022.
  • The 5-year median for Cash & Equivalents is $706.5 million (2022), against an average of $603.4 million.
  • The largest annual shift saw Cash & Equivalents plummeted 99.89% in 2022 before it soared 75368.1% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $964.1 million in 2021, then tumbled by 99.89% to $1.0 million in 2022, then skyrocketed by 75368.1% to $790.2 million in 2023, then plummeted by 43.09% to $449.7 million in 2024, then plummeted by 99.73% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Cash & Equivalents are $1.2 million (Q4 2025), $1.2 million (Q3 2025), and $732.2 million (Q2 2025).